Skintel logo reversed
Book Now

What your skin imaging report actually means (how to interpret the findings)

By Dr Maxton Bergin

Having a skin imaging test—such as mole mapping, dermoscopy photography or optical biopsy—can be reassuring, but receiving the report afterwards sometimes creates new questions. Patients often wonder whether phrases like “atypical,” “requires correlation” or “recommend biopsy” mean they should be worried, and how imaging findings relate to a final diagnosis.¹˒²˒³

This article explains what a skin imaging report is, why it matters, and how to read its main sections without trying to self‑diagnose. It also outlines how Skintel’s reports fit within your broader care, and why your referring doctor remains the key person to interpret the findings in context.⁹˒¹⁰˒¹¹

What is a skin imaging report?

A skin imaging report is a written summary of what a doctor sees on specialised images of your skin, such as total body photographs, close‑up dermoscopic images or reflectance confocal microscopy (optical biopsy) scans.⁴˒⁵˒¹² It describes:

  • which areas were imaged;

  • what each lesion looks like under magnification or cellular‑level imaging;

  • whether the features appear benign, suspicious or indeterminate;

  • recommendations for biopsy, treatment or follow‑up.⁵˒¹²˒¹³

Unlike histopathology (laboratory examination of tissue removed during a surgical biopsy), imaging reports are based on pictures taken with the skin intact.⁵˒¹³˒¹⁴ They are therefore best understood as decision‑support tools that help your doctor plan care, rather than as definitive diagnostic documents in their own right.⁵˒¹³˒¹⁴

Why imaging reports are important

High‑quality imaging helps doctors detect skin cancers earlier and more accurately, while reducing unnecessary biopsies of harmless moles.⁴˒⁵˒¹²˒¹⁵ Mole mapping allows subtle changes to be seen over time; dermoscopy photography preserves detailed views of lesions; and optical biopsy provides cellular‑level information without cutting the skin.⁴˒⁵˒¹²˒¹⁶˒¹⁷

Imaging reports capture this information in a structured format so your referring GP, dermatologist or surgeon can:

  • understand which lesions are of concern;

  • see how they appeared at the time of imaging;

  • track changes at future visits;

  • decide whether biopsy, surgery, topical treatment or monitoring is appropriate.⁵˒¹²˒¹³˒¹⁴

They also provide documentation that can be compared with later images, supporting long‑term surveillance in higher‑risk patients.⁴˒³˒¹⁵

Typical sections in a skin imaging report

Although formats vary between services, Skintel reports generally include the following sections.

Patient and referral details

This section lists your name, date of birth, referral source and imaging date, and may summarise relevant risk factors such as personal or family history of melanoma, number of moles or previous treatments.¹˒²˒³˒¹⁴ It helps ensure that the right report is matched to the right patient and gives your doctor context when interpreting the findings.

Imaging methods used

Here, the report outlines which modalities were performed—for example:

This section clarifies whether the findings are based on surface patterns, body‑wide mapping or cellular‑level imaging.

Lesion descriptions

The core of the report is a list of individual lesions, each with:

  • a location (eg “left upper back,” “right nasal ala”);

  • a brief clinical and dermoscopic description;

  • any confocal microscopy findings;

  • an impression such as “likely benign naevus,” “atypical lentiginous lesion” or “features suspicious for melanoma.”⁵˒¹²˒¹³

Some reports include numbered lesion IDs that correspond to photographs or body‑map diagrams, making it easier for your doctor to discuss specific spots with you.⁴˒¹⁵

Overall impression

This section summarises the main concerns and reassuring points. It may state, for example, that:

The overall impression is often the part patients focus on, but it needs to be read alongside your clinical history and examination.

Recommendations

Finally, the report provides practical recommendations, such as:

  • biopsy of particular lesions;

  • referral for surgical excision or Mohs surgery;

  • topical or non‑surgical treatments where appropriate;

  • timeframes for follow‑up imaging or skin checks;

  • reassurance that certain lesions can be watched rather than immediately treated.⁵˒¹³˒¹⁴

These recommendations are directed primarily to your referring doctor, who then discusses them with you and tailors them to your situation.¹¹˒¹³˒¹⁴

Common terms and what they usually mean

Patients often find the wording of imaging reports more confusing than the pictures themselves. Some frequently used terms include the following.

“Benign features”

This usually means the lesion shows patterns typical of harmless moles, seborrhoeic keratoses or other non‑cancerous conditions on dermoscopy or confocal microscopy.¹⁵˒¹⁸ Examples might include a regular pigment network, symmetrical structure or characteristic “stuck‑on” appearance.¹⁸˒¹⁹ While no test is perfect, “benign features” is generally reassuring, especially when it aligns with the clinical examination.³˒¹³˒¹⁴

“Atypical” or “atypical features”

“Atypical” means the lesion does not look completely typical for a common benign pattern, but also may not meet full criteria for melanoma or another cancer.¹⁵˒¹⁸ It often indicates that the doctor is cautious and recommends closer monitoring or biopsy, particularly if the lesion is changing or located on a high‑risk site such as the face or acral (the palms of the hands and the soles of the feet) skin.⁵˒¹²˒¹⁶˒²⁰

“Requires clinicopathologic correlation”

This phrase reminds readers that imaging findings must be interpreted together with physical examination and histopathology (laboratory examination of tissue removed during a surgical biopsy), not in isolation.⁵˒¹³˒¹⁴ It does not necessarily mean something is wrong; rather, it emphasises that the report alone cannot be used to make treatment decisions without the broader clinical picture.

“Recommend biopsy”

When imaging shows features suspicious for melanoma, basal cell carcinoma, squamous cell carcinoma or another significant condition, the report may advise biopsy.⁵˒¹³˒¹⁴ This is a strong recommendation to your referring doctor that tissue should be removed for histologic (microscopic) examination of the biopsy sample, even if confocal or dermoscopy suggest a likely diagnosis.¹³˒¹⁴

“Monitor” or “follow‑up imaging”

For lesions that appear benign but have minor atypical features or are located on cosmetically sensitive sites, the report may recommend repeat imaging or skin checks rather than immediate biopsy.⁴˒⁵˒¹²˒¹⁵ This approach aims to balance early detection with minimising unnecessary scars, particularly when changes over time are more informative than a single snapshot.⁴˒¹⁵

Which findings are usually reassuring?

In general, findings are more reassuring when:

  • lesions are described as having benign or typical features;¹⁵˒¹⁸

  • no lesions are flagged as “suspicious” or “recommend biopsy”;¹³˒¹⁴

  • follow‑up intervals are relatively long (eg routine annual checks rather than urgent reviews);³˒¹³

  • changes seen on mole mapping are subtle and consistent with normal ageing or sun damage.⁴˒¹⁵

However, even benign‑appearing lesions should continue to be checked if they change significantly or if you notice new symptoms such as bleeding, itching or rapid growth.²˒²¹

Which findings may require further assessment or treatment?

Findings are more concerning when:

  • one or more lesions are labelled “suspicious for melanoma” or “highly suggestive of basal cell carcinoma”;⁵˒¹³˒¹⁴

  • the report strongly recommends biopsy or urgent specialist review;¹³˒¹⁴˒¹⁵

  • confocal microscopy may reveal clear malignant features that help doctors determine whether a lesion is likely to represent skin cancer;⁵˒¹²˒¹⁶˒¹⁷

  • mole mapping shows rapid change in size, structure or new lesions in high‑risk patients.⁴˒³˒¹⁵

Even then, imaging results need to be confirmed with histopathology (laboratory examination of tissue removed during a surgical biopsy), and treatment decisions depend on factors such as your overall health, preferences and the lesion’s exact location.¹³˒¹⁴

How imaging reports differ from definitive diagnosis

It is important to understand that imaging reports do not replace biopsy and histopathology when tissue diagnosis is needed.⁵˒¹³˒¹⁴ For example:

  • Dermoscopy can strongly suggest melanoma, but histologic (microscopic) examination of a biopsy is still required to confirm the type, thickness and margins of the tumour.¹³˒¹⁸˒¹⁹

  • Confocal microscopy can reduce unnecessary biopsies and improve margin mapping (carefully defining the full extent of a tumour before surgical removal so the surgeon knows where the tumour begins and ends), but it does not fully subtype all tumours or assess deeper invasion.⁵˒¹²˒¹⁶˒¹⁷

  • Computer‑assisted analysis can highlight suspicious lesions, but these tools are used as decision support rather than primary diagnostics.¹²˒¹⁷˒²⁴

Histopathology (laboratory examination of tissue removed during a surgical biopsy) remains the gold standard for confirming skin cancer and guiding treatment.¹³˒¹⁴ Imaging reports should be seen as powerful tools to inform clinical judgement, not as stand‑alone verdicts.¹³˒¹⁴

Why imaging reports must be interpreted in clinical context

Two patients can have almost identical imaging findings but require different management because their risks, histories and preferences differ.¹˒²˒³˒¹³˒¹⁴ For example:

  • A stable, mildly atypical mole on the back of a low‑risk patient may be monitored.

  • The same pattern on the face of someone with multiple previous melanomas may warrant biopsy or confocal microscopy.⁵˒¹²˒¹⁶˒²⁰

Guidelines emphasise that imaging should be integrated with physical examination, risk assessment and histology, rather than used in isolation.¹³˒¹⁴˒¹⁵˒¹⁸˒²² That is why Skintel sends imaging reports back to your referring doctor, who knows your broader health picture and can discuss the results with you in person.⁹˒¹⁰˒¹¹

What happens after your skin imaging report is completed?

Once your imaging is performed and the doctor has reviewed the images, Skintel prepares a report outlining findings and recommendations.⁹˒¹⁰˒¹¹ The typical sequence is:

  1. Imaging session – clinical photographs, mole mapping, dermoscopy and optical biopsy as indicated.⁴˒⁵˒¹²˒¹⁶

  2. Doctor review – an experienced skin cancer doctor examines the images, correlates them with clinical notes and prepares a structured report.⁵˒¹²˒¹³

  3. Report sent to referring doctor – your GP, dermatologist or surgeon receives the report, along with images or body maps where relevant.⁹˒¹⁰˒¹¹

  4. Discussion and management plan – your referring doctor contacts you to discuss biopsy, treatment or follow‑up, and to integrate the findings into your overall care.¹³˒¹⁴

If you have not heard back within the expected timeframe, it is reasonable to contact your referring clinic to confirm that the report has been received and reviewed.

Why you should discuss the report with your doctor

Reading a skin imaging report without guidance can easily lead to unnecessary worry or false reassurance.¹˒²˒²¹ Your doctor can:

  • explain the meaning of technical terms in plain language;

  • show you the corresponding images and point out areas of concern or reassurance;

  • relate imaging findings to your personal risk factors and previous history;¹˒²˒³˒¹⁴

  • advise whether biopsy, treatment or simple observation is appropriate;¹³˒¹⁴

  • plan follow‑up intervals tailored to your situation.⁴˒³˒¹³

Self‑diagnosis based solely on imaging reports is unsafe. Even a report that sounds reassuring cannot replace professional assessment, particularly if you notice new or changing lesions.²˒²¹

Skintel’s role as a diagnostic imaging service

Skintel is a specialist diagnostic skin imaging service rather than a treatment clinic. The focus is on providing high‑quality imaging and expert interpretation to support your GP, dermatologist or surgeon.⁹˒¹⁰˒¹¹

At Skintel:

  • imaging reports are prepared following advanced assessments such as mole mapping, dermoscopy and confocal microscopy;⁴˒⁵˒¹²˒¹⁶

  • every report is reviewed by a skin cancer doctor with training in advanced imaging;⁵˒¹²˒¹⁷

  • findings are clearly documented but do not replace clinical judgement or histopathology (laboratory examination of tissue removed during a surgical biopsy);¹³˒¹⁴

  • reports and images are sent back to your referring doctor, who remains responsible for biopsy, treatment and ongoing management.⁹˒¹⁰˒¹¹

This model supports collaborative care, where imaging enhances diagnosis and monitoring while your usual doctor continues to lead decision‑making.¹³˒¹⁴

Frequently Asked Questions

What is a skin imaging report?

A skin imaging report is a written summary of what a doctor sees on specialised images of your skin, such as mole‑mapping photos, dermoscopic images and confocal microscopy scans.⁴˒⁵˒¹² It explains which lesions were imaged, how they appear, and whether biopsy, treatment or monitoring is recommended, but it does not replace histopathology (laboratory examination of tissue removed during a surgical biopsy).⁵˒¹³˒¹⁴

Does a normal skin imaging report mean I definitely don’t have skin cancer?

No. A report with only benign findings is reassuring, but no imaging test is perfect and some lesions can change between visits.³˒¹³˒¹⁴ Imaging results must be combined with your history, physical examination and—when needed—histologic (microscopic) examination of a biopsy to confirm a diagnosis, so it’s important to keep attending recommended skin checks.¹³˒¹⁴˒²¹

What does “recommend biopsy” in my report mean?

“Recommend biopsy” means that the doctor interpreting the images believes a tissue sample should be taken to confirm or exclude skin cancer.⁵˒¹³˒¹⁴ This is a strong suggestion to your referring doctor, who will discuss the reasons, risks and benefits with you and arrange an appropriate biopsy or specialist referral.

Why does my report say “requires clinicopathologic correlation”?

This phrase reminds readers that imaging findings must be interpreted alongside the physical examination and histopathology (laboratory examination of tissue removed during a surgical biopsy), not in isolation.⁵˒¹³˒¹⁴ It does not automatically mean something is wrong; instead, it emphasises that the report is one part of the overall clinical picture your doctor uses to make decisions.

Can I use my skin imaging report to diagnose myself?

No. Skin imaging reports contain technical language and are intended for doctors, not for self‑diagnosis.¹˒²˒²¹ Misinterpreting terms like “atypical” or “correlation required” can cause unnecessary anxiety or false reassurance. Always discuss your report with your GP or dermatologist, who can explain what it means in plain English and advise on next steps.³˒¹³˒¹⁴

How does mole mapping appear in a skin imaging report?

In mole‑mapping reports, lesions are usually labelled with numbers or coordinates that correspond to body‑map images and close‑up photographs.⁴˒¹⁵ The report notes which moles are stable, which have changed, and whether any new lesions have appeared, helping your doctor decide whether closer follow‑up or biopsy is needed.⁴˒³˒¹⁵

What role does confocal microscopy play in the report?

Confocal microscopy adds detailed cellular‑level information to the report, especially for facial and acral (palms and soles) lesions and complex tumours.⁵˒¹²˒¹⁶˒¹⁷ It can help distinguish benign from malignant patterns, refine margin mapping (defining exactly how far a tumour extends before surgery) and reduce unnecessary biopsies, but biopsies are still required when a definitive diagnosis or staging decision is needed.⁵˒¹³˒¹⁴

What should I do if I don’t understand my report?

If any part of your skin imaging report is unclear, make an appointment with your referring GP, dermatologist or surgeon to go through it together.¹˒²˒³˒¹⁴ Your doctor can explain the terminology, show you the images, and outline a management plan. Avoid trying to interpret the report solely with internet searches, as this can be misleading.²˒²¹

Disclaimer

All information is general and not intended as a substitute for professional advice.

References

  1. Cancer Council NSW. Checking for skin cancer. Sydney: Cancer Council NSW; 2025.

  2. Cancer Council Australia. Skin cancers. Sydney: Cancer Council Australia; 2026.

  3. Walker J, Sinclair R. Skin checks. Aust Fam Physician. 2012;41(7):460‑464.

  4. Tzellos T, Kyrgidis A, Zouboulis CC. The value of total body photography for the early detection of melanoma: a systematic review. J Eur Acad Dermatol Venereol. 2021;35(2):230‑237.

  5. Longo C, Ragazzi M, Rajadhyaksha M, et al. Reflectance confocal microscopy: an effective tool for diagnosing melanoma and non‑melanoma skin cancers. J Am Acad Dermatol. 2018;79(2):247‑257.

  6. Alam M, Ratner D. Cutaneous squamous‑cell carcinoma. N Engl J Med. 2001;344(13):975‑983.

  7. van der Veer WM, Bloemen MC, van der Wal MB, et al. Scar assessment tools: implications for clinical practice. J Am Acad Dermatol. 2009;60(4):707‑715.

  8. National Health and Medical Research Council. Clinical practice guidelines for the management of melanoma in Australia. Canberra: NHMRC; 2015.

  9. Skintel. Body Map – skin health and skin cancer detection. Melbourne: Skintel; 2025.

  10. Skintel. Our services – skin health and skin cancer detection. Melbourne: Skintel; 2026.

  11. Skintel. Referrals – skin cancer checks and confocal microscopy. Melbourne: Skintel; 2025.

  12. DermNet NZ. Reflectance confocal microscopy in dermatology. DermNet NZ; 2023.

  13. Cancer Council Australia. Clinical practice guidelines for the management of melanoma. Sydney: Cancer Council Australia; 2019.

  14. Cancer Council Victoria. Non‑melanoma skin cancer (BCC & SCC) – overview. Melbourne: Cancer Council Victoria; 2018.

  15. Malvehy J. Dermoscopy, confocal microscopy and other non‑invasive tools for skin cancer diagnosis and management. Acta Derm Venereol. 2017;97(1):5‑23.

  16. Mesquita Y, Tschandl P, et al. Reflectance confocal microscopy for margin mapping of lentigo maligna: systematic review and meta‑analysis. Br J Dermatol. 2025;192(4):e130‑e139.

  17. Waddell A, et al. Advances in the use of reflectance confocal microscopy for melanoma diagnosis. J Eur Acad Dermatol Venereol. 2018;32(9):1383‑1393.

  18. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3(3):159‑165.

  19. Menzies SW, Emery J, Staples M, et al. Impact of dermoscopy on the clinical diagnosis of melanoma in primary care: results of a randomised trial. BMJ. 2009;339:b3112.

  20. Reflectance confocal microscopy in lentigo maligna. Actas Dermosifiliogr. 2016;107(7):e507‑e513.

  21. Cancer Council Australia. Check for signs of skin cancer. Sydney: Cancer Council Australia; 2026.

  22. Horton L, et al. Review of non‑invasive imaging technologies for skin cancer diagnosis. Cancers (Basel). 2025;15(5):512.

  23. Skin Hospital. Confocal microscopy patient information. Sydney: Skin Hospital; 2025.

  24. Foltz EA, et al. Artificial intelligence applied to non‑invasive imaging for the diagnosis of skin cancer: systematic review. J Eur Acad Dermatol Venereol. 2024;38(4):e630‑e640.